Investors
|
Join Our Team

Immune Medicine

Immune Medicine Platform

The Adaptive Immune System

Research Publications
Products & Pipeline

Life Sciences Research

immunoSEQ

immunoSEQ T-MAP

Clinical Diagnostics

clonoSEQ

T-Detect

Drug Discovery

Cellular Therapy

Neutralizing Antibodies

Vaccines

Pipeline

Clinical Portfolio & Pipeline

Partners

Biopharma Partners

Technology Partners
News & Events

MEDIA

Press Releases

Media Resources

BLOG

New T-Detect COVID test

Julie Rubinstein Reflects on World Cancer Day

Learnings from the COVID-19 Immune Response Will Accelerate Healthcare Innovation

Powering the Age of Immune Medicine

See all posts

events

Conferences & Events

Webinars
Our Science

Clinical Studies

ImmuneRACE

ImmuneSense Lyme

medical

Medical Affairs

Medical Information

Data & Congresses

DATA PROGRAMS

ImmuneCODE

ImmuneACCESS

PUBLICATIONS

Research Publications

EDUCATION

SEQdiscovery
About Us

ABOUT US

Who We Are

Our Story

Innovation Timeline

Leadership

INVESTORS

Investor Relations

Newsroom

CONNECT

Contact

Careers

IMMUNE MEDICINE
PRODUCTS & PIPELINE
NEWS & EVENTS
OUR SCIENCE
ABOUT US
- ABOUT US
- Who We Are
- Our Story
- Innovation Timeline
- Leadership
- INVESTORS
- Investor Relations
- Newsroom
- CONNECT
- Contact
- Careers

Menu

IMMUNE MEDICINE
PRODUCTS & PIPELINE
NEWS & EVENTS
OUR SCIENCE
ABOUT US
- ABOUT US
- Who We Are
- Our Story
- Innovation Timeline
- Leadership
- INVESTORS
- Investor Relations
- Newsroom
- CONNECT
- Contact
- Careers

Uniquely equipped to achieve our bold vision

Adaptive Leadership

Board of Directors

Leadership

Chad Robins

Chief Executive Officer,

Co-founder,

Chairman of the Board

Harlan Robins, PhD

Chief Scientific Officer

& Co-founder

Julie Rubinstein

President

Chad Cohen

Chief Financial Officer

Lance Baldo, MD

Chief Medical Officer

Mark Adams, PhD

Chief Operating Officer

Francis Lo

Chief People Officer

Sharon Benzeno, PhD

Chief Business Development Officer

Jyoti Palaniappan

Senior Vice President, Diagnostics,

T-Detect

Susan Bobulsky

Senior Vice President, Diagnostics,

clonoSEQ

Stacy Taylor

Senior Vice President,

General Counsel

Board of Directors

Chad Robins

Chief Executive Officer,

Co-founder,

Chairman of the Board

Peter Neupert

Board Member

Kevin Conroy

Board Member

Eric Dobmeier

Board Member

David Goel

Board Member

Michelle Griffin

Board Member

Robert Hershberg, MD, PhD

Board Member

Mike Pellini, MD

Board Member

Read the latest
from Adaptive

Immune Medicine

Immune Medicine Platform
The Adaptive Immune
System
Research Publications

Products & Platform

immunoSEQ
immunoSEQ T-MAP
clonoSEQ
T-Detect
Cellular Therapy
Neutralizing Antibodies
Vaccines
Pipeline
Technology Partners
Biopharma Partnerships

News & Events

Press Releases
Blog
Media Resources
Webinars
Conferences & Events

Our Science

ImmuneRACE
ImmuneSense Lyme
Research Publications
ImmuneCODE
ImmuneACCESS
Medical Affairs
Medical Information
Data & Congresses
SEQDiscovery

About Us

Who We Are
Our Story
Innovation Timeline
Leadership
Investor Relations
Newsroom
Careers
Contact Us

Diagnostics (888) 552-8988 | Corporate/Research (855) 466-8667

© Adaptive Biotechnologies. All Rights Reserved. Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

© Adaptive Biotechnologies. All Rights Reserved.
Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

Diagnostics (888) 552-8988

Corporate/Research (855) 466-8667

© Adaptive Biotechnologies. All Rights Reserved.

Online Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

STAY IN TOUCH

Receive the latest

Adaptive news and updates

Your email is safe with us. Read our Privacy Policy.

Announcing FDA Emergency Use Authorization for T-Detect™ COVID

Read More